{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T18:00:59Z","timestamp":1793556059302,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-995557"],"award-info":[{"award-number":["R-995557"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-939667"],"award-info":[{"award-number":["R-939667"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-995882"],"award-info":[{"award-number":["R-995882"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005041","name":"Universit\u00e9 Catholique de Louvain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031015","name":"Hospital Cl\u00ednic de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003509","name":"\u00d6rebro Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014148","name":"Centro Hospitalar Universit\u00e1rio do Porto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-1000881"],"award-info":[{"award-number":["OLL-1000881"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20200017"],"award-info":[{"award-number":["20200017"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["FAI-2023-1006"],"award-info":[{"award-number":["FAI-2023-1006"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2024-49"],"award-info":[{"award-number":["2024-49"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015763","name":"Szegedi Tudom\u00e1nyegyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009806","name":"Ulla and Gustaf af Ugglas Foundation","doi-asserted-by":"publisher","award":["2023-025029"],"award-info":[{"award-number":["2023-025029"]}],"id":[{"id":"10.13039\/501100009806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","award":["FAI-2023-1055"],"award-info":[{"award-number":["FAI-2023-1055"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["671_2018"],"award-info":[{"award-number":["671_2018"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-974449"],"award-info":[{"award-number":["SLS-974449"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018780","name":"Servicio Andaluz de Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Professor Nanna Svartz Foundation Fund","doi-asserted-by":"publisher","award":["2021-00436"],"award-info":[{"award-number":["2021-00436"]}],"id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ard.2025.04.008","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:58:40Z","timestamp":1746806320000},"page":"1164-1179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-9471","authenticated-orcid":false,"given":"Julius","family":"Lindblom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-6629","authenticated-orcid":false,"given":"Denis","family":"Lagutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Sherina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-4729","authenticated-orcid":false,"given":"Helena","family":"Idborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-9678","authenticated-orcid":false,"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jousse-Joulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lauwerys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Maudoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel Gonzalez-Gay","family":"Mantec\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Blanco","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso Corrales","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hunzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Belz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Baerlecken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Collantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Angeles","family":"Aguirre-Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Escudero-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Carmen","family":"Castro-Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Concepci\u00f3n Fern\u00e1ndez","family":"Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada Jim\u00e9nez","family":"Mole\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"de Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel D\u00edaz","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Schioppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chizzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatienne","family":"Wynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Balog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolna","family":"De\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Bocskai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Dulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"K\u00e1d\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Hiepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Rodriguez","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez-Berrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Aguilar-Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Navarro-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-2470","authenticated-orcid":false,"given":"Janique M.","family":"Peyper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-4154","authenticated-orcid":false,"given":"Marta E.","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10441","key":"10.1016\/j.ard.2025.04.008_bib0001","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/antib5010002","article-title":"Autoantibodies in SLE: specificities, isotypes and receptors","volume":"5","author":"Dema","year":"2016","journal-title":"Antibodies (Basel)"},{"issue":"5640","key":"10.1016\/j.ard.2025.04.008_bib0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/271067a0","article-title":"Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors","volume":"271","author":"Alarcon-Segovia","year":"1978","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/BOR.0000000000000862","article-title":"Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights","volume":"34","author":"Lindblom","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0006","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.ard.2025.04.008_bib0007","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11926-013-0343-1","article-title":"Clinical significance of IgA anti-cardiolipin and IgA anti-beta2glycoprotein I antibodies","volume":"15","author":"Andreoli","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.ard.2025.04.008_bib0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3899\/jrheum.121094","article-title":"Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study","volume":"40","author":"Gladman","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000372","article-title":"High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus","volume":"7","author":"Koelmeyer","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.04.008_bib0011","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1016\/S2665-9913(22)00304-6","article-title":"Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study","volume":"4","author":"Kandane-Rathnayake","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2025.04.008_bib0012","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/rheumatology\/keac185","article-title":"Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus","volume":"61","author":"Emamikia","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.04.008_bib0013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/rheumatology\/keae120","article-title":"Lupus low disease activity state and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up","volume":"64","author":"Parodis","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ard.2025.04.008_bib0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard-2023-224795","article-title":"Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort","volume":"83","author":"Parodis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1016\/j.ard.2025.04.008_bib0015","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.3390\/jcm12196268","article-title":"Huang X. B cell tolerance and targeted therapies in SLE","volume":"12","author":"Parodis","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ard.2025.04.008_bib0016","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.04.008_bib0017","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0018","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0019","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S2665-9913(19)30037-2","article-title":"Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study","volume":"1","author":"Golder","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"4","key":"10.1016\/j.ard.2025.04.008_bib0021","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ard.2025.04.008_bib0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ard.2025.04.008_bib0023","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/pmic.200300722","article-title":"Functional protein microarrays for parallel characterisation of p53 mutants","volume":"4","author":"Boutell","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.ard.2025.04.008_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1257085","article-title":"PRECISESADS Clinical Consortium, Alarc\u00f3n-Riquelme ME, Parodis I. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus","volume":"14","author":"Lindblom","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ard.2025.04.008_bib0025","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ard.2025.04.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.04.003","article-title":"New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and nonlupus autoimmunity\u2212could anti-LIN28A enhance precision in diagnostics?","author":"Parodis","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.04.008_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.009","article-title":"Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus","volume":"91","author":"Lewis","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ard.2025.04.008_bib0028","article-title":"Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.ard.2025.04.008_bib0029","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.celrep.2018.07.105","article-title":"Lin28 signaling supports mammalian PNS and CNS axon regeneration","volume":"24","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ard.2025.04.008_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fgene.2017.00031","article-title":"The LIN28\/let-7 pathway in cancer","volume":"8","author":"Balzeau","year":"2017","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0031","first-page":"vdaa174","article-title":"Lin28A\/let-7 oncogenic circuit is a potential therapeutic target in neurocutaneous melanosis-associated CNS tumors in children","volume":"3","author":"Jain","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"10","key":"10.1016\/j.ard.2025.04.008_bib0032","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.7150\/ijbs.97434","article-title":"Nephron-specific Lin28A overexpression triggers severe inflammatory response and kidney damage","volume":"20","author":"Futorian","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10.1016\/j.ard.2025.04.008_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13707","article-title":"Lin28a forms an RNA-binding complex with Igf2bp3 to regulate m6A-modified stress response genes in stress granules of muscle stem cells","volume":"57","author":"Song","year":"2024","journal-title":"Cell Prolif"},{"issue":"10","key":"10.1016\/j.ard.2025.04.008_bib0034","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1093\/nar\/gkq1343","article-title":"Effects of HMGN variants on the cellular transcription profile","volume":"39","author":"Rochman","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2006.12.001","article-title":"HMG chromosomal proteins in development and disease","volume":"17","author":"Hock","year":"2007","journal-title":"Trends Cell Biol"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0036","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clim.2014.06.001","article-title":"IRF5-mediated signaling and implications for SLE","volume":"153","author":"Lazzari","year":"2014","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.008_bib0037","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ard.2025.04.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ard.2025.04.008_bib0039","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2019.01029","article-title":"Circulating levels of interferon regulatory factor-5 associates with subgroups of systemic lupus erythematosus patients","volume":"10","author":"Idborg","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ard.2025.04.008_bib0040","first-page":"376","article-title":"Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry","volume":"36","author":"Bo","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ard.2025.04.008_bib0041","article-title":"Antibody response to homologous epitopes of Epstein-Barr virus, Mycobacterium avium subsp. paratuberculosis and IRF5 in patients with different connective tissue diseases and in mouse model of antigen-induced arthritis","volume":"3","author":"Bo","year":"2020","journal-title":"J Transl Autoimmun"},{"issue":"9","key":"10.1016\/j.ard.2025.04.008_bib0042","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.ard.2025.04.008_bib0043","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/biom13010073","article-title":"Serum levels of transforming growth factor beta 1 in systemic lupus erythematosus patients","volume":"13","author":"G\u00f3mez-Bernal","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)80712-6","article-title":"A Smad transcriptional corepressor","volume":"97","author":"Wotton","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0046","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2004.02587.x","article-title":"Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus","volume":"138","author":"Mandel","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"6286","key":"10.1016\/j.ard.2025.04.008_bib0047","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/346719a0","article-title":"Stimulation of p21ras upon T-cell activation","volume":"346","author":"Downward","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ard.2025.04.008_bib0048","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2008.102780","article-title":"Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus","volume":"69","author":"Molad","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"36","key":"10.1016\/j.ard.2025.04.008_bib0049","doi-asserted-by":"crossref","first-page":"57593","DOI":"10.18632\/oncotarget.11419","article-title":"Downregulation of the phosphatase JKAP\/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis","volume":"7","author":"Chuang","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.ard.2025.04.008_bib0050","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ard.2025.04.008_bib0051","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clim.2018.10.001","article-title":"Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis","volume":"197","author":"Xu","year":"2018","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.ard.2025.04.008_bib0052","article-title":"Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant","volume":"3","author":"Wang","year":"2023","journal-title":"Cell Genom"},{"issue":"8","key":"10.1016\/j.ard.2025.04.008_bib0053","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ard.2025.04.008_bib0054","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.10978","article-title":"Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus","volume":"48","author":"Jury","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.04.008_bib0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/ard-2023-225266","article-title":"The role of DNA in the pathogenesis of SLE: DNA as a molecular chameleon","volume":"83","author":"Pisetsky","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2025.04.008_bib0056","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI42856","article-title":"Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice","volume":"120","author":"Biswas","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ard.2025.04.008_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.ard.2025.04.008_bib0058","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2353\/ajpath.2007.070188","article-title":"Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability","volume":"171","author":"Ding","year":"2007","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.ard.2025.04.008_bib0059","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/14397595.2018.1432331","article-title":"Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus","volume":"28","author":"Ishii","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ard.2025.04.008_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756941","article-title":"Clinical experience of proteasome inhibitor bortezomib regarding efficacy and safety in severe systemic lupus erythematosus: a nationwide study","volume":"12","author":"Walhelm","year":"2021","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.ard.2025.04.008_bib0061","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1177\/0961203320959696","article-title":"Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform","volume":"29","author":"Mak","year":"2020","journal-title":"Lupus"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:08:01Z","timestamp":1778040481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725008969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0003496725008969"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.008","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}